Results 131 to 140 of about 10,726 (197)

Expanding the Biocatalytic Toolbox: A Singular P450 Enzyme Efficiently Produces Diverse Pharmaceutical Metabolites. [PDF]

ACS Omega
Jeffreys LN, Thistlethwaite S, Cliff MJ, Poddar H, Bhanot S, Tunnicliffe RB, Golovanova M, Hollywood K, Levy CW, Voice MW, Leys D, McLean KJ, Waltho JP, Munro AW, Girvan HM.   +14 more
europepmc   +1 more source

Expanding the Gene Expression Profiling of Drug Transporters and Drug-Metabolizing Enzymes to Include the Upper Female Reproductive Tract. [PDF]

Pharmaceutics
Le A, Valicherla GR, Zhang J, Wang L, Donnelly MK, Bies R, Rohan LC.   +6 more
europepmc   +1 more source

EFFECTS OF CYP2C8 INHIBITORS ON REPAGLINIDE METABOLISM

Abstracts of Annual meeting of Japanese Society for the Study of Xenobiotics, 2009
Inoue, Tomoko, Matsuda, Michiaki, Shimakura, Jin, Natsui, Kiyoshi, Hashizume, Takanori, Yabuki, Masashi, Komuro, Setsuko   +6 more
openaire   +1 more source

Factors Influencing Phenoconversion in CYP-Mediated Drug Metabolism: A Scoping Review. [PDF]

Pharmacy (Basel)
Scodellaro S, Triantafilou S, Cohn I.
europepmc   +1 more source

Drug-drug interactions with pioglitazone, losartan, and midazolam and anti-tumor efficacy and safety study of TAS-115 in patients with solid tumors. [PDF]

Cancer Chemother Pharmacol
Katsuya Y, Takenaka S, Takahashi S, Yamamoto N.   +3 more
europepmc   +1 more source

Pharmacogenetics and Molecular Ancestry of <i>SLC22A1</i>, <i>SLC22A2</i>, <i>SLC22A3</i>, <i>ABCB1</i>, <i>CYP2C8</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Ecuadorian Subjects with Type 2 Diabetes Mellitus. [PDF]

Pharmaceuticals (Basel)
Ortega-Ayala A, de la Cruz CG, Mora L, Bonilla M, Tana L, Rodrigues-Soares F, Dorado P, LLerena A, Terán E.   +8 more
europepmc   +1 more source

Beyond the Very Important Pharmacogenes (VIPs): Uncovering Shadow Pharmacogenes in the Human Drug Response Network. [PDF]

ACS Omega
de Melo NC, Accioli GS, Sánchez-Luquez K, Gomes MFF, Felicio AC, de Carvalho LM.   +5 more
europepmc   +1 more source

Managing Drug-Drug Interactions Involving the Non-Prescription Opioid Loperamide Through Physiologically Based Pharmacokinetic Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Zhou Z, Ainslie GR, Li M, Dinh J, Zamek-Gliszczynski MJ, Zhao P, Paine MF.   +6 more
europepmc   +1 more source

Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma. [PDF]

Med Sci (Basel)
Jung HS, Baek GO, Yoon MG, Jang SH, Cheong JY, Kim SS, Eun JW.   +6 more
europepmc   +1 more source

Comparative Analysis of Antidepressant Mechanisms and Side Effects: Network Pharmacology and Molecular Docking Study of Amitriptyline, Mirtazapine, and Escitalopram for Treating Major Depressive Disorder. [PDF]

Depress Anxiety
Zhuo C, Zhang Q, Song H, Zou J, Li R, Ma X, Chen X, Li Y, Yang L, Wang L, Li C, Tian H.   +11 more
europepmc   +1 more source